Kyle Mikson

Stock Analyst at Canaccord Genuity

(0)
# 4948
Out of 5,270 analysts
84
Total ratings
12.24%
Success rate
-32.32%
Average return
22 Stocks
Name Action Price Target Current % Upside Ratings Updated
Natera
Maintains: Strong Buy
180 195
143.16 36.21% 8 Feb 28, 2025
Guardant Health
Maintains: Strong Buy
42 60
40.76 47.2% 5 Feb 24, 2025
Repligen
Maintains: Hold
165 170
155.4 9.4% 2 Feb 21, 2025
10x Genomics
Maintains: Buy
20 18
9.85 82.74% 7 Feb 13, 2025
Illumina
Maintains: Hold
145 135
84.2 60.33% 7 Feb 7, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
5 7
3.01 132.56% 2 Jan 3, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
6 4
1.55 125.81% 3 Nov 15, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
3 3
1.36 120.59% 4 Nov 14, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Hold
2 1
1.29 -22.48% 3 Nov 13, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
95 75
47.6 57.56% 9 Nov 6, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
35 42
21.34 96.81% 3 Oct 29, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
4 3
1.31 129.01% 7 Aug 8, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Hold
3 5
0.13 3746.15% 3 Jul 30, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
32 25
7.13 250.63% 4 Apr 29, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Hold
26
n/a n/a 2 Mar 26, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
4
0.71 392.96% 2 Mar 4, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
5 2
n/a n/a 4 Nov 27, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Hold
3
n/a n/a 4 Sep 25, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Overweight
3 2
0.61 227.87% 2 Aug 16, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Overweight
50
0.7 6928.57% 1 Mar 30, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Overweight
19
2.36 705.08% 1 Jan 29, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Overweight
150
0.17 88135.29% 1 Jan 29, 2021